+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Meningitis Vaccines Market

  • ID: 4769265
  • Report
  • Region: Global
  • 312 pages
  • Research Nester Pvt. Ltd
1 of 5

FEATURED COMPANIES

  • GlaxosmithKline
  • Janssen
  • Merck and Company
  • Panacea
  • Pfizer
  • Sanofi Pasteur
  • MORE

The global market of meningitis vaccine stood at USD 12,783.1 Million in 2018 and is expected to reach USD 27,522.5 Million by the end of 2027, expanding at a CAGR of 8.9% over the forecast period i.e. 2019-2027. The advancements in meningitis vaccine and growing healthcare sector globally is anticipated to further boost the demand for meningitis vaccine in future.

Geographically, North America accounted for the largest market share of 41.2% in 2018 in the revenue of meningitis vaccine market globally. The market of North America region is expected to continue its dominance over the forecast period on the back of rising demand for efficient disease preventive Vaccine across the region.

Robust research and development are going on in healthcare sector to manufacture advanced and cost-effective meningitis Vaccine. The advanced meningitis vaccine further provides precise and accurate dosing with minimalist side effects to the vaccinated population.

The adoption of advanced and high end Vaccine is rising in developing regions such as India, China, Japan and others. To gain a competitive edge, different manufacturers of medical equipment have come up with various new Vaccine to effectively aid in the prevention of meningitis.

With USD 5,999.9 Million revenue by the end of 2027 in the global market, Asia-Pacific Meningitis Vaccine market is expected to showcase lucrative growth over the forecast period. This growth is primarily attributed on the back of increasing governing regulatory body initiatives in order to reduce the number of deaths caused to meningitis across the region.

With the increasing focus of people on healthcare, the Asia-Pacific meningitis vaccine market is expected to witness rapid growth throughout the forecast period. Asia-Pacific market is expected to expand at a CAGR of 9.4% over the forecast period and expected to contribute a market share of 21.8% in global meningitis vaccine market.

Additionally, favorable government initiatives to develop the healthcare infrastructure coupled with increasing healthcare expenditure across the globe is envisioned to bolster the growth of the meningitis Vaccine market robustly over the forecast period.

Moreover, Europe is estimated to grow at a CAGR of 8.7% over the forecast period contributing a market share of 25.6% in the year 2027 in the global meningitis market.

Some of the leading manufacturers in this market are Sanofi Pasteur, GSK, Pfizer, Merck and Essilor among others.

READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • GlaxosmithKline
  • Janssen
  • Merck and Company
  • Panacea
  • Pfizer
  • Sanofi Pasteur
  • MORE
1. Introduction
1.1. Market Definition
1.2. Product Overview
1.3. Market Segmentation
1.4. Features by Popular Products Available

2. Assumptions and Acronyms

3. Research Methodology

4. Executive Summary- Global Meningitis Vaccine Market

5. Market Dynamics
5.1. Drivers
5.2. Restraints
5.3. Trends
5.4. Opportunities

6. Risk Analysis
6.1. Demand Risk
6.2. Supply Risk

7. Global Meningitis Vaccine Market Outlook
7.1. Market Size and Forecast, 2018-2027
7.1.1. By Value (USD Million)
7.1.1.1. Y-o-Y Growth (%), 2019-2027
7.2. Market Share and Forecast, 2018-2027
7.2.1. By Vaccine
7.2.1.1. Meningitis Vaccine Market Share (%), By Vaccine (2018, 2027F)
7.2.1.1.1. Meningococcal Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
7.2.1.1.1.1. MenB, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
7.2.1.1.1.2. MenC, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
7.2.1.1.1.3. MenACWY, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
7.2.1.1.2. Pneumococcal vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
7.2.1.1.2.1. PCV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
7.2.1.1.2.2. PPV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
7.2.1.1.3. Hib, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
7.2.1.2. Market Attractiveness Analysis, By Vaccine
7.2.1.3. Market Contribution and BPS Analysis, 2018 & 2027, By Vaccine
7.2.2. By Composition
7.2.2.1. Meningitis Vaccine Market Share (%), By Composition (2018, 2027F)
7.2.2.1.1. Polysaccharide Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
7.2.2.1.2. Conjugate Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
7.2.2.1.3. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
7.2.2.2. Market Attractiveness Analysis, By Composition
7.2.2.3. Market Contribution and BPS Analysis, 2018 & 2027, By Composition
7.2.3. By End User
7.2.3.1. Meningitis Vaccine Market Share (%), By End User (2018, 2027F)
7.2.3.1.1. Hospitals, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
7.2.3.1.2. Clinics, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
7.2.3.1.3. Ambulatory Surgical centers, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
7.2.3.1.4. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
7.2.3.2. Market Attractiveness Analysis, By End User
7.2.3.3. Market Contribution and BPS Analysis, 2018 & 2027, By End User
7.2.4. By Region
7.2.4.1. Meningitis Vaccine Market Share (%), By Region (2018,2027F)
7.2.4.1.1. North America
7.2.4.1.2. Europe
7.2.4.1.3. Asia Pacific
7.2.4.1.4. Latin America
7.2.4.1.5. Middle East and Africa

8. North America Meningitis Vaccine Market Outlook
8.1. Macro-Economic Indicators impacting the North America Meningitis Vaccine Market
8.2. Market Size and Forecast, 2018-2027
8.2.1. By Value (USD Million)
8.2.1.1. Y-o-Y Growth (%), 2019-2027
8.3. Market Share and Forecast, 2018-2027
8.3.1. By Vaccine
8.3.1.1. Meningitis Vaccine Market Share (%), By Vaccine (2018, 2027F)
8.3.1.1.1. Meningococcal Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
8.3.1.1.1.1. MenB, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
8.3.1.1.1.2. MenC, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
8.3.1.1.1.3. MenACWY, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
8.3.1.1.2. Pneumococcal vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
8.3.1.1.2.1. PCV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
8.3.1.1.2.2. PPV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
8.3.1.1.3. Hib, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
8.3.1.2. Market Attractiveness Analysis, By Vaccine
8.3.1.3. Market Contribution and BPS Analysis, 2018 & 2027, By Vaccine
8.3.2. By Composition
8.3.2.1. Meningitis Vaccine Market Share (%), By Composition (2018, 2027F)
8.3.2.1.1. Polysaccharide Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
8.3.2.1.2. Conjugate Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
8.3.2.1.3. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
8.3.2.2. Market Attractiveness Analysis, By Composition
8.3.2.3. Market Contribution and BPS Analysis, 2018 & 2027, By Composition
8.3.3. By End User
8.3.3.1. Meningitis Vaccine Market Share (%), By End User (2018, 2027F)
8.3.3.1.1. Hospitals, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
8.3.3.1.2. Clinics, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
8.3.3.1.3. Ambulatory Surgical centers, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
8.3.3.1.4. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
8.3.3.2. Market Attractiveness Analysis, By End User
8.3.3.3. Market Contribution and BPS Analysis, 2018 & 2027, By End User
8.3.4. By Country
8.3.4.1. Meningitis Vaccine Market Share (%), By Country (2018,2027F)
8.3.4.1.1. United States & Canada, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027

9. Europe Meningitis Vaccine Market Outlook
9.1. Macro-Economic Indicators impacting the Europe Meningitis Vaccine Market
9.2. Market Size and Forecast, 2018-2027
9.2.1. By Value (USD Million)
9.2.1.1. Y-o-Y Growth (%), 2019-2027
9.3. Market Share and Forecast, 2018-2027
9.3.1. By Vaccine
9.3.1.1. Meningitis Vaccine Market Share (%), By Vaccine (2018, 2027F)
9.3.1.1.1. Meningococcal Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
9.3.1.1.1.1. MenB, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
9.3.1.1.1.2. MenC, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
9.3.1.1.1.3. MenACWY, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
9.3.1.1.2. Pneumococcal vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
9.3.1.1.2.1. PCV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
9.3.1.1.2.2. PPV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
9.3.1.1.3. Hib, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
9.3.1.2. Market Attractiveness Analysis, By Vaccine
9.3.1.3. Market Contribution and BPS Analysis, 2018 & 2027, By Vaccine
9.3.2. By Composition
9.3.2.1. Meningitis Vaccine Market Share (%), By Composition (2018, 2027F)
9.3.2.1.1. Polysaccharide Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
9.3.2.1.2. Conjugate Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
9.3.2.1.3. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
9.3.2.2. Market Attractiveness Analysis, By Composition
9.3.2.3. Market Contribution and BPS Analysis, 2018 & 2027, By Composition
9.3.3. By End User
9.3.3.1. Meningitis Vaccine Market Share (%), By End User (2018, 2027F)
9.3.3.1.1. Hospitals, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
9.3.3.1.2. Clinics, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
9.3.3.1.3. Ambulatory Surgical centers, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
9.3.3.1.4. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
9.3.3.2. Market Attractiveness Analysis, By End User
9.3.3.3. Market Contribution and BPS Analysis, 2018 & 2027, By End User
9.3.4. By Country
9.3.4.1. Meningitis Vaccine Market Share (%), By Country (2018,2027F)
9.3.4.1.1. Germany, United Kingdom & France, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
9.3.4.1.2. Italy, Spain & Turkey, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
9.3.4.1.3. Russia & rest of Europe, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027

10. Asia Pacific Meningitis Vaccine Market Outlook
10.1. Macro-Economic Indicators impacting the Asia Pacific Meningitis Vaccine Market
10.2. Market Size and Forecast, 2018-2027
10.2.1. By Value (USD Million)
10.2.1.1. Y-o-Y Growth (%), 2019-2027
10.3. Market Share and Forecast, 2018-2027
10.3.1. By Vaccine
10.3.1.1. Meningitis Vaccine Market Share (%), By Vaccine (2018, 2027F)
10.3.1.1.1. Meningococcal Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
10.3.1.1.1.1. MenB, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
10.3.1.1.1.2. MenC, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
10.3.1.1.1.3. MenACWY, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
10.3.1.1.2. Pneumococcal vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
10.3.1.1.2.1. PCV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
10.3.1.1.2.2. PPV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
10.3.1.1.3. Hib, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
10.3.1.2. Market Attractiveness Analysis, By Vaccine
10.3.1.3. Market Contribution and BPS Analysis, 2018 & 2027, By Vaccine
10.3.2. By Composition
10.3.2.1. Meningitis Vaccine Market Share (%), By Composition (2018, 2027F)
10.3.2.1.1. Polysaccharide Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
10.3.2.1.2. Conjugate Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
10.3.2.1.3. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
10.3.2.2. Market Attractiveness Analysis, By Composition
10.3.2.3. Market Contribution and BPS Analysis, 2018 & 2027, By Composition
10.3.3. By End User
10.3.3.1. Meningitis Vaccine Market Share (%), By End User (2018, 2027F)
10.3.3.1.1. Hospitals, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
10.3.3.1.2. Clinics, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
10.3.3.1.3. Ambulatory Surgical centers, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
10.3.3.1.4. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
10.3.3.2. Market Attractiveness Analysis, By End User
10.3.3.3. Market Contribution and BPS Analysis, 2018 & 2027, By End User
10.3.4. By Country
10.3.4.1. Meningitis Vaccine Market Share (%), By Country (2018,2027F)
10.3.4.1.1. India, China and Japan, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
10.3.4.1.2. South Korea, Australia & Rest of Asia Pacific 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027

11. Latin America Meningitis Vaccine Market Outlook
11.1. Macro-Economic Indicators impacting the Latin America Meningitis Vaccine Market
11.2. Market Size and Forecast, 2018-2027
11.2.1. By Value (USD Million)
11.2.1.1. Y-o-Y Growth (%), 2019-2027
11.3. Market Share and Forecast, 2018-2027
11.3.1. By Vaccine
11.3.1.1. Meningitis Vaccine Market Share (%), By Vaccine (2018, 2027F)
11.3.1.1.1. Meningococcal Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
11.3.1.1.1.1. MenB, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
11.3.1.1.1.2. MenC, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
11.3.1.1.1.3. MenACWY, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
11.3.1.1.2. Pneumococcal vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
11.3.1.1.2.1. PCV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
11.3.1.1.2.2. PPV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
11.3.1.1.3. Hib, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
11.3.1.2. Market Attractiveness Analysis, By Vaccine
11.3.1.3. Market Contribution and BPS Analysis, 2018 & 2027, By Vaccine
11.3.2. By Composition
11.3.2.1. Meningitis Vaccine Market Share (%), By Composition (2018, 2027F)
11.3.2.1.1. Polysaccharide Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
11.3.2.1.2. Conjugate Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
11.3.2.1.3. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
11.3.2.2. Market Attractiveness Analysis, By Composition
11.3.2.3. Market Contribution and BPS Analysis, 2018 & 2027, By Composition
11.3.3. By End User
11.3.3.1. Meningitis Vaccine Market Share (%), By End User (2018, 2027F)
11.3.3.1.1. Hospitals, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
11.3.3.1.2. Clinics, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
11.3.3.1.3. Ambulatory Surgical centers, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
11.3.3.1.4. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
11.3.3.2. Market Attractiveness Analysis, By End User
11.3.3.3. Market Contribution and BPS Analysis, 2018 & 2027, By End User
11.3.4. By Country
11.3.4.1. Meningitis Vaccine Market Share (%), By Country (2018,2027F)
11.3.4.1.1. Brazil, Mexico & Rest of Latin America, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027

12. Middle East and Africa Meningitis Vaccine Market Outlook
12.1. Macro-Economic Indicators impacting the Middle East and Africa Meningitis Vaccine Market
12.2. Market Size and Forecast, 2018-2027
12.2.1. By Value (USD Million)
12.2.1.1. Y-o-Y Growth (%), 2019-2027
12.3. Market Share and Forecast, 2018-2027
12.3.1. By Vaccine
12.3.1.1. Meningitis Vaccine Market Share (%), By Vaccine (2018, 2027F)
12.3.1.1.1. Meningococcal Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
12.3.1.1.1.1. MenB, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
12.3.1.1.1.2. MenC, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
12.3.1.1.1.3. MenACWY, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
12.3.1.1.2. Pneumococcal vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
12.3.1.1.2.1. PCV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
12.3.1.1.2.2. PPV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
12.3.1.1.3. Hib, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
12.3.1.2. Market Attractiveness Analysis, By Vaccine
12.3.1.3. Market Contribution and BPS Analysis, 2018 & 2027, By Vaccine
12.3.2. By Composition
12.3.2.1. Meningitis Vaccine Market Share (%), By Composition (2018, 2027F)
12.3.2.1.1. Polysaccharide Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
12.3.2.1.2. Conjugate Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
12.3.2.1.3. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
12.3.2.2. Market Attractiveness Analysis, By Composition
12.3.2.3. Market Contribution and BPS Analysis, 2018 & 2027, By Composition
12.3.3. By End User
12.3.3.1. Meningitis Vaccine Market Share (%), By End User (2018, 2027F)
12.3.3.1.1. Hospitals, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
12.3.3.1.2. Clinics, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
12.3.3.1.3. Ambulatory Surgical centers, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
12.3.3.1.4. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
12.3.3.2. Market Attractiveness Analysis, By End User
12.3.3.3. Market Contribution and BPS Analysis, 2018 & 2027, By End User
12.3.4. By Country
12.3.4.1. Meningitis Vaccine Market Share (%), By Country (2018,2027F)
12.3.4.1.1. Middle East & Africa, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
12.3.4.1.1.1. North Africa, South Africa & Rest of Africa, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027

13. Competitive Landscape
13.1. Competitive Positioning of Major Players in Global Meningitis Vaccine Market
13.2. Company Profiles
13.2.1. GlaxoSmithKline plc
13.2.1.1. Company Overview
13.2.1.2. Business Strategy
13.2.1.2.1. Growth Expansion Strategy
13.2.1.2.2. Distribution Channel Strategy
13.2.1.2.3. Product Strategy
13.2.1.3. Key Product Offerings
13.2.1.4. Financial Performance
13.2.1.5. Key Performance Indicators
13.2.1.6. Risk Analysis
13.2.1.7. Recent Development
13.2.1.8. Regional Presence
13.2.1.9. SWOT Analysis
13.2.2. Pfizer Inc.
13.2.3. Sanofi Pasteur SA
13.2.4. Merck & Co., Inc.
13.2.5. Janssen
13.2.6. Panacea
13.2.7. Hualan Biological Engineering Inc.
13.2.8. Serum Institute of India Ltd.
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • GlaxosmithKline
  • Pfizer
  • Sanofi Pasteur
  • Merck and Company
  • Janssen
  • Panacea
  • Hualan Biological Engineering Inc.
  • Serum Institute of India
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

6 of 5
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4769265
Adroll
adroll